Genvax

Genvax

We accelerate breakthrough solutions to the animal health industry.

Founded 2021

Ames, United States 11 employees Venture round Total: $10.04M Biotechnology

Genvax is a biotechnology startup based in Ames, Iowa, founded in 2021. The company's mission revolves around accelerating breakthrough solutions in the animal health industry. Genvax aims to develop next-generation RNA + nanoparticle vaccines for animal health, leveraging the expertise of its dynamic team of experienced scientists and entrepreneurs. Having a notable track record, co-founders Joel Harris and Dr. Hank Harris previously established and successfully sold Harrisvaccines to Merck Animal Health in 2015. Their recent Seed Round investment of $6.50 million on 10th August 2022 was supported by key investors including Rural Vitality Funds, Ag Startup Engine, Johnsonville Ventures, United Health Foundation, and Summit Agricultural Group. Genvax's vision emphasizes the rapid response to global demands, aiming to commercialize tools for livestock producers and veterinarians that are unparalleled in the market. The company seeks to cultivate new ideas to develop novel solutions and create a long-lasting impact on animal health worldwide. This demonstrates their commitment to creating a significant impact in the industry as they accelerate breakthrough solutions for the betterment of animal health.

Funding Stage	Amount	Investors	Lead Investors	Date
Venture Round	$3.40M	-		24 Jun 2024
Seed Round	$6.50M	5	Rural Vitality Funds, Ag Startup Engine +3	10 Aug 2022
Grant	$145.00K	2	Agricultural Research Service, Foundation for Food and Agriculture Research	01 Apr 2022

Funding Stage

Amount

Investors

Lead Investors

Date

Venture Round

$3.40M

24 Jun 2024

Seed Round

$6.50M

Rural Vitality Funds, Ag Startup Engine +3

10 Aug 2022

Grant

$145.00K

Agricultural Research Service, Foundation for Food and Agriculture Research

01 Apr 2022

FAQ About Genvax

We accelerate breakthrough solutions to the animal health industry.

Genvax was founded in 2021.

Genvax is headquartered in Ames, United States.

Genvax operates in Biotechnology. Its work centres on Animal Health, vaccine development, RNA technology and Nanoparticle vaccines.

Genvax has approximately 11 employees.

Genvax has completed 3 funding rounds, raising a total of $10.04M. The latest funding stage is Venture round.

Top alternatives and competitors to Genvax include Moredun Research Institute, ZeaVaxx, Torigen, Inc., FeedVax, Alytix. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

Genvax and Moredun Research Institute are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

General Information

Discover More

About Genvax

Funding Rounds & Investors (3)

Genvax Alternatives & Competitors

FAQ About Genvax